GALWAY, IRELAND--November 18, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Takeda Pharmaceutical (Osaka, Japan) has officially opened its new manufacturing plant in Singen, Germany, for its planned dengue vaccine, TAK-003, which is still in Phase 3 trials. Within this article: Details opening of new plant, planned dengue vaccine, investment, schedule, related Takeda business and assets sales
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
